Company profile
TScan Therapeutics
Unleash Immunity
- Industry
- Biotechnology Research
- Employees
- 154
- Headquarters
- Waltham, Massachusetts
- Founded
- 2018
- LinkedIn followers
- 11,488
- Office locations
- 1
TScan Therapeutics company summary
TScan Therapeutics is a company in the Biotechnology Research industry, headquartered in Waltham, Massachusetts, founded in 2018. On LinkedIn the company has around 154 employees and 11,488 followers. Its listed specialties include TCR-T Cell Therapy.
What technology does TScan Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About TScan Therapeutics
TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system. TScan Therapeutics is a fully integrated, next-generation TCR-T cell therapy company. Founded in 2018, TScan’s platform was developed by Stephen Elledge, Ph.D., and Tomasz Kula, Ph.D., at Brigham and Women’s Hospital and Harvard Medical School. TScan’s transformative platform enables rapid discovery of TCRs and targets for engineered T cell therapy. This technology is extremely versatile and is applicable across multiple therapeutic areas beyond cancers, including autoimmune disorders and infectious diseases.
Specialties
Where is TScan Therapeutics located?
TScan Therapeutics lists 1 location.
Compare companies similar to TScan Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
TScan Therapeutics tscan.com | Biotechnology Research | 154 | 2018 | Waltham, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about TScan Therapeutics
What does TScan Therapeutics do?
TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system. TScan Therapeutics is a fully integrated, next-generation TCR-T cell therapy company. Founded in 2018, TScan’s platform was developed by Stephen Elledge, Ph.D., and Tomasz Kula, Ph.D., at Brigham and Women’s Hospital and Harvard Medical School. TScan’s transformative platform enables rapid discovery of TCRs and targets for engineered T cell therapy. This technology is extremely versatile and is applicable across multiple therapeutic areas beyond cancers, including autoimmune disorders and infectious diseases.
How many employees does TScan Therapeutics have?
TScan Therapeutics has around 154 employees on LinkedIn.
Where is TScan Therapeutics headquartered?
TScan Therapeutics is headquartered in Waltham, Massachusetts.
When was TScan Therapeutics founded?
TScan Therapeutics was founded in 2018.
Build a lead list from companies like TScan Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.